Their agreement serves several purposes: - A Phase 3 trial in Thailand of an HIV vaccine, ALVAC vCP1521 prime plus AIDSVAX B/E gp120 boost - Developing infrastructure, training programs, and other activities geared toward conducting HIV vaccine trials in Africa, as well as other international initiatives - USMHRP's outpatient clinical vaccine trial facility and specimen processing/repository facil